Donepezil Double Blind Trial for ECT Memory Disfunction
Status:
Unknown status
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
This is a double blind randomized investigation of donepezil for patients suffering from
schizophrenia, undergoing ECT.
Patients will be randomized to receive either donezepil or plasebo, in order to gauge whether
donezepil has a protective effect on memory disfunction, while patients are treated with ECT.
Several parameters will be invistigated at baseline: general psychopathological measures,
memory function scales, side effects scales. The same measurements will be taken throughout
the trial and one month after ending the ECT.